Allworth Financial’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.72K | Hold |
748
| – | – | ﹤0.01% | 3563 |
|
|
2025
Q1 | $1.71K | Hold |
748
| – | – | ﹤0.01% | 3261 |
|
|
2024
Q4 | $1.79K | Hold |
748
| – | – | ﹤0.01% | 3185 |
|
|
2024
Q3 | $988 | Hold |
748
| – | – | ﹤0.01% | 3218 |
|
|
2024
Q2 | $1.01K | Hold |
748
| – | – | ﹤0.01% | 3155 |
|
|
2024
Q1 | $1.37K | Hold |
748
| – | – | ﹤0.01% | 2968 |
|
|
2023
Q4 | $928 | Hold |
748
| – | – | ﹤0.01% | 2971 |
|
|
2023
Q3 | $853 | Hold |
748
| – | – | ﹤0.01% | 2897 |
|
|
2023
Q2 | $685 | Hold |
748
| – | – | ﹤0.01% | 2831 |
|
|
2023
Q1 | $420 | Hold |
748
| – | – | ﹤0.01% | 2873 |
|
|
2022
Q4 | $432 | Buy |
+748
| New | +$432 | ﹤0.01% | 2669 |
|
|
2021
Q1 | – | Sell |
-748
| Closed | -$2K | – | 1474 |
|
|
2020
Q4 | $2K | Hold |
748
| – | – | ﹤0.01% | 1125 |
|
|
2020
Q3 | $2K | Hold |
748
| – | – | ﹤0.01% | 966 |
|
|
2020
Q2 | $10K | Hold |
748
| – | – | ﹤0.01% | 716 |
|
|
2020
Q1 | $6K | Hold |
748
| – | – | ﹤0.01% | 815 |
|
|
2019
Q4 | $5K | Hold |
748
| – | – | ﹤0.01% | 753 |
|
|
2019
Q3 | $3K | Hold |
748
| – | – | ﹤0.01% | 745 |
|
|
2019
Q2 | $4K | Hold |
748
| – | – | ﹤0.01% | 694 |
|
|
2019
Q1 | $6K | Hold |
748
| – | – | ﹤0.01% | 637 |
|
|
2018
Q4 | $4K | Buy |
+748
| New | +$4K | ﹤0.01% | 631 |
|